Search

Your search keyword '"Chopra, Dhruv"' showing total 15 results
Start Over Author "Chopra, Dhruv"
15 results on '"Chopra, Dhruv"'

2. An Interpretive Structural Modelling Approach to Analyse Interaction between Performance Management Factors in the Current Business Ecosystem.

Author

Chopra, Dhruv, Banwet, D. K., and Nigam, Shalini

Subjects
PERFORMANCE management, BUSINESS ecosystems, TELECOMMUTING, COVID-19 pandemic, LABOR incentives
Abstract

This paper presents an overview on the change in the dynamics of the Performance Management process in the current business ecosystem which is majorly by technology in the post pandemic era. Be it work from home or Hybrid work options at the work place, every factor of Performance Management structure is critically analysed in this study and inter-dependencies of these factors in today's virtual business ecosystem is highlighted too. A total of 7 critical elements of performance management were identified basis the critical literature review and through discussion and brainstorming sessions with managers and employee representatives and structured using pair-wise comparison. Structural and reachability matrices were formed and yielded a level of influence of each factor through Interpretive Structural Modelling (ISM) approach. MICMAC analysis was conducted to determine the dependency and driving power of these elements. The present study can be differentiated from the past studies on identified Performance Management as factors like Biasness of Manager and Relatable Past Performance which do play a critical role in evaluation but has not been extensively categorised in the framework earlier. This will help the managers, researchers and organizational specialists to encompass overall factors in assessing the performance of their teams without any biasness. [ABSTRACT FROM AUTHOR]

Published
2022

15. Better Together? Costs of First-line Chemoimmunotherapy for Advanced Non-Small Cell Lung Cancer.

Author

Kish, Jonathan, Liassou, Djibril, Hartman, John, Lubinga, Solomon J., Chopra, Dhruv, and Feinberg, Bruce

Subjects
*THERAPEUTIC use of antineoplastic agents, *LUNG cancer, *CONFIDENCE intervals, *CANCER chemotherapy, *ANTINEOPLASTIC agents, *MEDICAL care costs, *RETROSPECTIVE studies, *MEDICAL care use, *DESCRIPTIVE statistics, *RESEARCH funding, *IMMUNOTHERAPY
Abstract

OBJECTIVES: Recent advances have created options for first-line (1L) treatment of advanced/metastatic non--small cell lung cancer (aNSCLC). The study objectives were to describe the utilization of 3 classes of 1L treatment--chemotherapy (CT), immunotherapy (IO), and chemoimmunotherapy (IO+CT)--and the total, third-party payer, direct health care costs. STUDY DESIGN: Retrospective, administrative claims database analysis of patients with aNSCLC who initiated 1L treatment between January 1, 2017, and May 31, 2019, with IO, CT, or IO+CT. METHODS: Microcosting enumerated health care resource utilization, including antineoplastic drug costs, using standardized costs. Generalized linear models estimated per-patient per-month (PPPM) costs during 1L treatment, and adjusted cost differences in 1L among treatment cohorts were calculated using recycled predictions. RESULTS: A total of 1317 IO-, 5315 CT-, and 1522 IO+CTtreated patients were identified. Utilization of CT declined from 72.3% to 47.6% between 2017 and 2019, replaced by use of IO+CT, which increased from 1.8% to 29.8%. Total PPPM costs in 1L were highest with IO+CT at $32,436, compared with $19,000 and $17,763 in the CT and IO cohorts, respectively. Adjusted analyses showed that PPPM costs were $13,933 (95% CI, $11,760-$16,105) higher in the IO+CT vs IO cohort (P < .001) and IO costs were $1024 (95% CI, $67-$1980) lower than CT (P = .04). CONCLUSIONS: IO+CT accounts for almost one-third of 1L aNSCLC treatment modalities, coinciding with a reduction in treatment with CT. Costs for patients treated with IO were lower than those for patients treated with both IO+CT and CT alone, driven primarily by antineoplastic drug and associated medical costs. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results